Peptidomimetics are small molecules that mimic short natural proteins - peptides - and produce the same effects as their natural counterparts. An EU-funded project is developing peptidomimetics that can alternate between biologically active and inactive forms when exposed to light. The technique could lead to new light-controlled drugs which can be turned off and on when needed to treat cancers and other diseases.
EU-funded researchers have demonstrated huge potential for treating aggressive brain cancer using actively personalised immunotherapy in a first first-stage clinical trial to test the vaccine's safety.
An EU-funded project has developed a technique to design and synthesise highly stable proteins. The approach enables proteins to be made from scratch, tailored to carry out specific tasks for advances in fields such as biomedicine and biotech - boosting Europe's competitiveness.
Advanced imaging technologies are revolutionising biological and biomedical science. An EU-funded project enabled researchers worldwide to better access cutting-edge biological and medical imaging technologies, to accelerate the great societal benefits this technological revolution will provide.
An EU-funded project is using synthetic biology techniques to design broad-spectra vaccines against mycoplasmas and viral infections in farm animals. By designing a growth medium without animal components and developing a platform to engineer new vaccines, the project will give the EU livestock industry a much-needed boost.
Tissue engineering is used to grow alternatives to donor tissue, but getting this tissue to integrate in patients has previously proved complicated. An EU-funded project addressed this problem by developing an innovative modular approach to engineering complex tissues with different cell types.
Various options exist for the replacement of failing heart valves. However, none of the conventional ones are particularly well suited to persons in their teens or twenties, say EU-funded researchers who have developed an innovative solution to boost such patients' chances of leading normal lives.
Human welfare is closely linked to the health of animals and the environment. An EU-funded joint research programme has been created to align developments in medicine, veterinary science and consumer health protection to tackle food-borne health threats in a more integrated way across Europe.
Microfluidic bioreactors allow chemical reactions to take place on a very small scale, saving time, money and materials. An EU-funded project has developed microfluidic bioreactor technologies that could lead to a wide range of applications, including innovative medicines.
An EU-funded project is enabling young European biomedical researchers to organise annual scientific symposia, career days and outreach activities. The aim is to connect them with prominent scientists and give them the skills and experience to advance their own careers.
